8-K

MIMEDX GROUP, INC. (MDXG)

8-K 2025-06-20 For: 2025-06-18
View Original
Added on April 04, 2026

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

____________________

FORM 8-K ____________________

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): June 18, 2025

MIMEDX GROUP, INC.

(Exact name of registrant as specified in charter)

Florida 001-35887 26-2792552
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)

1775 West Oak Commons Ct., NE, Marietta GA 30062

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (770) 651-9100

____________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange<br>on which registered
Common Stock, $0.001 par value per share MDXG The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.07    Submission of Matters to a Vote of Security Holders.

On June 18, 2025, the Company held its 2025 Annual Meeting of Shareholders (the “2025 Annual Meeting”).

At the 2025 Annual Meeting, 126,620,293 shares of Company common stock (i.e., approximately 85.7% of votes entitled to be cast at the 2025 Annual Meeting) were represented in person or by proxy.

At the 2025 Annual Meeting, the shareholders: (1) re-elected M. Kathleen Behrens, Ph.D., Joseph H. Capper, James L. Bierman, William A. Hawkins, III, Cato T. Laurencin, M.D., K. Todd Newton, Tiffany Olson, Dorothy Puhy, and Martin P. Sutter, (2) approved an advisory resolution regarding executive compensation, (3) certified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025, (4) approved an amendment of the Company’s 2016 Equity and Cash Incentive Plan, and (5) approved an advisory resolution for an annual shareholder vote on executive compensation,

Set forth below is information regarding the votes cast for each proposal.

Proposal 1: Election of Nine Directors.

For Against Abstain Broker Non-Votes
M. Kathleen Behrens 91,972,156 9,879,214 61,741 24,707,182
Joseph H. Capper 95,965,049 5,907,223 40,839 24,707,182
James L. Bierman 97,144,748 4,711,520 56,843 24,707,182
William A. Hawkins, III 95,312,036 6,511,171 89,904 24,707,182
Cato T. Laurencin 97,246,926 4,513,738 152,447 24,707,182
K. Todd Newton 96,774,711 5,002,007 136,393 24,707,182
Tiffany Olson 96,835,684 5,014,632 62,795 24,707,182
Dorothy Puhy 95,383,954 6,462,064 67,093 24,707,182
Martin P. Sutter 94,553,803 7,301,165 58,143 24,707,182

Proposal 2: Advisory approval of executive compensation.

For Against Abstain Broker Non-Votes
Total Shares Voted 94,778,256 6,924,968 209,887 24,707,182

Proposal 3: Ratification of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025.

For Against Abstain Broker Non-Votes
Total Shares Voted 123,672,273 970,687 1,977,333 N/A

Proposal 4: Approval of the amendment of the Company’s 2016 Cash and Equity Incentive Plan.

For Against Abstain Broker Non-Votes
Total Shares Voted 91,371,825 10,344,239 197,047 24,707,182

Proposal 5: Advisory approval of the frequency of the shareholder vote on executive compensation.

One year Two years Three years Abstain
Total Shares Voted 97,503,345 462,185 2,446,853 1,500,728

Say-on-Pay Frequency Determination

In light of the shareholder advisory vote, the Company has determined that future advisory Say on Pay votes will occur every year until the next advisory vote regarding such frequency.

Exhibit No. Description of Exhibit
104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.

SIGNATURES

Pursuant to the requirements of the Exchange Act, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

MIMEDX GROUP, INC.
June 20, 2025 By: /s/ William “Butch” Hulse
William “Butch” Hulse<br>General Counsel & Chief Administrative Officer